Multiple Myeloma: Front Line Therapy and Autologous Stem Cell Transplantation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Multiple Myeloma: Front Line Therapy and Autologous Stem Cell Transplantation ; volume:54 ; number:02 ; year:2018 ; pages:096-105
Annals of National Academy of Medical Sciences (India) ; 54, Heft 02 (2018), 096-105
- Beteiligte Personen und Organisationen
-
Kumar, Lalit
- DOI
-
10.1055/s-0040-1712792
- URN
-
urn:nbn:de:101:1-2020070907512785098448
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kumar, Lalit
Ähnliche Objekte (12)
Current status of autologous stem cell transplantation for multiple myeloma
Multiple Myeloma Involving Skin and Pulmonary Parenchyma after Autologous Stem Cell Transplantation
Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma
Tandem Autologous Hematopoietic Stem Cell Transplantation in Very Young Patients with Multiple Myeloma
Patients with multiple myeloma infected with COVID-19 during autologous stem cell transplantation
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation
Real-word data on autologous stem cell transplantation in older patients with multiple myeloma
Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantation
Current status of autologous stem cell transplantation for multiple myeloma
Multiple Myeloma Involving Skin and Pulmonary Parenchyma after Autologous Stem Cell Transplantation
Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma
Tandem Autologous Hematopoietic Stem Cell Transplantation in Very Young Patients with Multiple Myeloma
Patients with multiple myeloma infected with COVID-19 during autologous stem cell transplantation
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation
Real-word data on autologous stem cell transplantation in older patients with multiple myeloma
Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantation
Current status of autologous stem cell transplantation for multiple myeloma
Multiple Myeloma Involving Skin and Pulmonary Parenchyma after Autologous Stem Cell Transplantation
Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myeloma
Tandem Autologous Hematopoietic Stem Cell Transplantation in Very Young Patients with Multiple Myeloma
Patients with multiple myeloma infected with COVID-19 during autologous stem cell transplantation
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation
Real-word data on autologous stem cell transplantation in older patients with multiple myeloma